Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Lucile CapuronAndrew H Miller

Abstract

We have previously shown that the risk of major depression in patients with malignant melanoma undergoing interferon-alpha (IFN-alpha) therapy can be reduced by pretreatment with the antidepressant, paroxetine. Using dimensional analyses, the present study assessed the expression and treatment responsiveness of specific clusters of neuropsychiatric symptoms over the first three months of IFN-alpha therapy. Forty patients with malignant melanoma eligible for IFN-alpha treatment were randomly assigned to receive either paroxetine or placebo in a double-blind design. Neuropsychiatric assessments were conducted at regular intervals during the first twelve weeks of IFN-alpha therapy and included the 21-item Hamilton Depression Rating Scale, the 14-item Hamilton Anxiety Rating Scale and the Neurotoxicity Rating Scale. Neurovegetative and somatic symptoms including anorexia, fatigue and pain appeared within two weeks of IFN-alpha therapy in a large proportion of patients. In contrast, symptoms of depressed mood, anxiety and cognitive dysfunction appeared later during IFN-alpha treatment and more specifically in patients who met DSM-IV criteria for major depression. Symptoms of depression, anxiety, cognitive dysfunction and pain were m...Continue Reading

Citations

May 9, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Krista M RubinIlana M Braun
May 31, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nicholas CourtierMalcolm D Mason
Mar 1, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Masatoshi InagakiYosuke Uchitomi
Aug 28, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Mark S Cooper, Vincent P Clark
Jan 27, 2007·Current Oncology Reports·H Florence Kim, Michael J Fisch
Jul 13, 2006·Current Pain and Headache Reports·Mellar P DavisGuang H Yue
Jul 16, 2008·Current Pain and Headache Reports·Mitchell R Levy, Jesse R Fann
Oct 12, 2005·Current Psychiatry Reports·Alan D Valentine, Christina A Meyers
Sep 20, 2011·Current Psychiatry Reports·Charles L Raison, Andrew H Miller
Nov 4, 2006·Current Treatment Options in Gastroenterology·Muhamad Aly RifaiPeter Hauser
Aug 5, 2005·Current Treatment Options in Neurology·Raphael J Leo
Mar 31, 2004·Brain, Behavior, and Immunity·Kathy L KopniskyDianne M Rausch
May 26, 2004·Brain, Behavior, and Immunity·Michael IrwinCindy Ehlers
Aug 9, 2005·Biological Psychiatry·Lucile CapuronAndrew H Miller
Aug 3, 2012·Journal of Affective Disorders·J A ArcherA Korszun
Mar 1, 2005·Journal of Pain and Symptom Management·Richard Benoit Francoeur
May 12, 2005·Neuroscience and Biobehavioral Reviews·Adrian J DunnRenaud de Beaurepaire
May 24, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gregory M Asnis, Richard De La Garza
Oct 29, 2002·Brain, Behavior, and Immunity·Lucile CapuronPierre J Neveu
Mar 5, 2003·Brain, Behavior, and Immunity·Lucile Capuron, Robert Dantzer
Mar 5, 2003·Brain, Behavior, and Immunity·Andrew H Miller
Feb 1, 2012·Molecular Psychiatry·C L Raison, A H Miller
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francis E LotrichRobert E Ferrell
May 10, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer C FelgerAndrew H Miller
Aug 6, 2011·Nature Reviews. Immunology·Michael R Irwin, Steven W Cole
Dec 13, 2007·Nature Reviews. Neuroscience·Robert DantzerKeith W Kelley
Jan 6, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronWilliam C Reeves
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naoko KanekoShigenobu Kanba
Dec 8, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Francis E LotrichPeter Hauser
Aug 25, 2011·Journal of Palliative Medicine·Jordanka KirkovaMellar P Davis
Oct 7, 2004·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Diana L SylvestreHenry Francis
Sep 28, 2004·Journal of Pediatric Gastroenterology and Nutrition·Eva SzigethyWilliam R Beardslee
Apr 25, 2006·Journal of Clinical Gastroenterology·Gregory M Asnis, Richard De La Garza
Jul 28, 2010·Clinical Neuropharmacology·Francis E LotrichBruce G Pollock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Masatoshi InagakiYosuke Uchitomi
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Dominique L MusselmanAndrew H Miller
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Nicholas CourtierMalcolm D Mason
© 2022 Meta ULC. All rights reserved